Atlas Trials

Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Stimulation on Smoking Consumption in Type 2 Diabetes Patients

Clinical trial NCT06924697 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06924697
Sponsor
Shanghai East Hospital
Status
ENROLLING_BY_INVITATION
Phase
Not Applicable
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2Nicotine Dependence, Cigarettes
Start date
2025-06-21
Primary completion
2026-01-11
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.